Tenaya Therapeutics, Inc.
TNYA
$1.22
-$0.06-4.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.92% | 13.33% | -12.70% | 7.01% | 12.90% |
| Total Depreciation and Amortization | -10.56% | -21.68% | 27.38% | -0.57% | -1.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.48% | 1.17% | 2.98% | -12.35% | -10.94% |
| Change in Net Operating Assets | -191.46% | 129.32% | -231.56% | 21.34% | 32.08% |
| Cash from Operations | 0.09% | 32.45% | -25.69% | 7.30% | 16.01% |
| Capital Expenditure | 81.69% | 62.92% | -87.75% | -10.87% | -152.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.64% | 10.78% | 58.56% | 147.83% | -237.93% |
| Cash from Investing | -64.54% | 12.04% | 58.14% | 146.86% | -239.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 13,231.30% | 1,116.13% | -94.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 179.83% | -100.95% | 13,231.30% | 1,116.13% | -94.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.46% | -82.00% | 1,365.33% | 92.17% | -3,384.85% |